Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Lifecare AS ( (DE:LFC0) ).
Lifecare ASA announced that CEO Joacim Holter will participate in a strategic update event, highlighting the company’s plans to leverage its ‘second mover’ advantage in the growing CGM market. The company aims for significant value creation with a capital-efficient commercialization strategy, targeting a USD 1 billion revenue potential and a 35%+ EBITDA margin, with key milestones including a veterinary market launch in late 2025 and a European human market launch in 2027.
More about Lifecare AS
Lifecare ASA is a medical technology company specializing in the development of next-generation continuous glucose monitoring (CGM) systems for diabetes management. The company focuses on utilizing osmotic pressure as a sensing principle to monitor various body analytes, catering to both human and veterinary markets.
Average Trading Volume: 26,178
Current Market Cap: NOK129.7M
See more insights into LFC0 stock on TipRanks’ Stock Analysis page.